Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-06-15 16:09:46 ET · period of report 2026-06-12 · accession 0001159036-26-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:09 | 2026-06-12 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | +5,034 | 52.6K | +11% | $0 |
| D | 2026-06-15 16:09 | 2026-06-12 | HALO | Snyder Mark Howard | SVP, CLO | F - Tax | $69.50 | -2,715 | 49.9K | -5% | -$188.7K |
| D | 2026-06-15 16:09 | 2026-06-12 | HALO | Snyder Mark Howard | SVP, CLO | M - OptEx | $0.00 | -5,034 | 10.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | M | A | 5,034 | $0.00 | 52,644 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-12 | F | D | 2,715 | $69.50 | 49,929 | D | — | — | (F1) The reported disposition of 2,715 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Derivative | Restricted Stock Units | 2026-06-12 | M | D | 5,034 | $0.00 | 10,068 | D | $0.00 · — to — | 5,034 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |